# Unraveling the role of amphisomes in mast cell secretory granule fusion and exosome release

**Authors:** Irene Tsilioni

PMC · DOI: 10.20517/evcna.2024.96 · 2025-03-24

## TL;DR

This paper explores how amphisomes help mast cells release inflammatory mediators and exosomes, changing our understanding of granule function.

## Contribution

The study introduces a novel model of secretory granule fusion involving amphisomes and lipid signaling.

## Key findings

- Amphisomes act as intermediates in secretory granule maturation and fusion.
- Lipid signaling via PI4K and CD63 coordinates granule fusion and exosome release.
- Secretory granules are dynamic hubs, not static storage compartments.

## Abstract

Mast cells (MCs) play a crucial role in immune responses by storing and releasing inflammatory mediators from secretory granules (SGs). The biogenesis, maturation, and fusion of these granules with the plasma membrane regulate inflammation, immune cell recruitment, and tissue homeostasis. However, the exact mechanism underlying this process remains unclear. Recent studies have identified a novel mechanism of SG fusion involving amphisomes, hybrid organelles formed by the fusion of late endosomes and autophagosomes. This process not only facilitates SG enlargement but also promotes the release of exosomes, small vesicles crucial for intercellular communication and immune modulation. In particular, Omari et al. delve into the molecular machinery governing amphisome formation and SG fusion, focusing on key players such as Rab5, PTPN9, CD63, and phosphoinositides (PIs). They propose a dynamic model wherein amphisomes act as intermediates in SG maturation, promoting homotypic fusion events that regulate SG content and size. A critical aspect of this process is the lipid signaling cascade, particularly involving PI4K and CD63, which coordinates SG fusion and exosome release. These findings challenge the conventional view of SGs as static storage compartments, positioning them as dynamic hubs of vesicle trafficking and secretion. By elucidating the role of amphisomes and lipid signaling in SG biology, this study offers a significant shift in understanding and introduces new concepts that could drive future research. This commentary, while endorsing the authors’ key conclusions, also highlights important questions regarding the functional implications of these novel mechanisms and their potential therapeutic applications.

## Linked entities

- **Genes:** RAB5A (RAB5A, member RAS oncogene family) [NCBI Gene 5868], PTPN9 (protein tyrosine phosphatase non-receptor type 9) [NCBI Gene 5780], CD63 (CD63 molecule) [NCBI Gene 967], CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase) [NCBI Gene 10423], PI4K (phosphatidylinositol 4-kinase) [NCBI Gene 857415]

## Full-text entities

- **Genes:** CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, RAB5A (RAB5A, member RAS oncogene family) [NCBI Gene 5868] {aka RAB5}, PTPN9 (protein tyrosine phosphatase non-receptor type 9) [NCBI Gene 5780] {aka MEG2, PTPMEG2}
- **Diseases:** inflammation (MESH:D007249)

---
Source: https://tomesphere.com/paper/PMC11977352